Literature DB >> 20492611

ABO hemolytic disease of the fetus and newborn: an iatrogenic complication of heterologous assisted reproductive technology-induced pregnancy.

Antonio Alberto Zuppa1, Valentina Cardiello, Marco Lai, Luigi Cataldi, Vito D'Andrea, Costantino Romagnoli.   

Abstract

BACKGROUND: ABO hemolytic disease of the fetus and newborn (ABO HDFN) may manifest itself in cases of mothers belonging to blood group O and newborns of groups A or B and more frequently in group A and less so in group B. CASE STUDY: The case subjects are twin-birth newborns with ABO HDFN, of group AB born to a mother of group O. These cases of ABO HDFN prove inconsistent with Mendel's law of segregation. RESULTS AND
CONCLUSION: This case study finds its explanation in new methods of assisted reproduction, particularly heterologous in vitro fertilization with ovodonation.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20492611     DOI: 10.1111/j.1537-2995.2010.02698.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Retrospective analysis of 55 twin neonates with haemolytic disease of the newborn.

Authors:  Hu Zhao; Bijuan Li; Ning Li; Yamei Shen; Kailiang Liu; Xiangwu Shu; Cheng Mei; Lanlan Tang
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

2.  Quantitative and multiplexed detection for blood typing based on quantum dot-magnetic bead assay.

Authors:  Ting Xu; Qiang Zhang; Ya-Han Fan; Ru-Qing Li; Hua Lu; Shu-Ming Zhao; Tian-Lun Jiang
Journal:  Int J Nanomedicine       Date:  2017-04-26

3.  Relationship between ABO blood group and Acute Lymphoblastic Leukemia.

Authors:  F Tavasolian; E Abdollahi; M Vakili; A Amini
Journal:  Iran J Ped Hematol Oncol       Date:  2014-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.